(VIANEWS) – Good morning! Another day of trading is almost starting and here’s today’s list of stocks that have had significant trading activity in the US premarket session.

The three most active and biggest winners today are Box, Zscaler, and Li Auto.

Rank Financial Asset Price Premarket
Change
Updated (EST)
1 Box (BOX) 25.64 9.53% 2021-12-01 05:07:55
2 Zscaler (ZS) 368.70 6.26% 2021-12-01 07:21:24
3 Li Auto (LI) 37.35 5.39% 2021-12-01 07:33:54
4 Merck (MRK) 78.88 5.3% 2021-12-01 05:02:38
5 POSCO (PKX) 58.00 5.13% 2021-12-01 07:28:00
6 Flex (FLEX) 17.93 4.85% 2021-12-01 07:26:12
7 Canon (CAJ) 23.00 4.55% 2021-12-01 07:23:04
8 Sypris Solutions (SYPR) 2.80 4.48% 2021-12-01 04:55:31
9 CNH Industrial (CNHI) 17.08 4.4% 2021-12-01 07:23:37
10 Groupon (GRPN) 21.50 4.07% 2021-12-01 07:26:52

The three most active and biggest losers today are Salesforce, Telefonica, and Moderna.

Rank Financial Asset Price Premarket
Change
Updated (EST)
1 Salesforce (CRM) 268.00 -5.95% 2021-12-01 04:59:12
2 Telefonica (TEF) 4.34 -3.77% 2021-12-01 05:05:25
3 Moderna (MRNA) 343.00 -2.68% 2021-12-01 07:19:06
4 Arcturus Therapeutics (ARCT) 38.80 -2.39% 2021-12-01 07:32:09
5 BioNTech SE (BNTX) 344.58 -2.04% 2021-12-01 04:55:57
6 Zebra Technologies (ZBRA) 578.00 -1.83% 2021-12-01 07:31:54
7 ImmunoGen (IMGN) 6.07 -1.6% 2021-12-01 07:27:25
8 CME Group (CME) 217.16 -1.52% 2021-12-01 07:24:22
9 Novavax (NVAX) 205.47 -1.51% 2021-12-01 07:29:05
10 Huazhu Group (HTHT) 38.96 -1.42% 2021-12-01 07:27:07

Most Active Premarket Winners today

1. Box (BOX) – Premarket: 9.53%

NYSE Composite ended the session with Box falling 0% to $23.41 on Wednesday, after two successive sessions in a row of losses. NYSE Composite slid 0% to $16,318.97, following the last session’s downward trend on what was a somewhat bullish trend trading session today.

Volume

Today’s last reported volume for Box is 3235630, 41.56% above its average volume of 2285700.

Box’s last close was $23.41, 14.59% below its 52-week high of $27.41.

The company’s growth estimates for the current quarter is 5% and a drop 4.5% for the next.

Volatility

Box’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.25%, a negative 0.38%, and a positive 1.54%, respectively.

Box’s highest amplitude of average volatility was 1.55% (last week), 1.28% (last month), and 1.54% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Box’s stock is considered to be oversold (<=20).

Box’s Stock Yearly Top and Bottom Value

Box’s stock is valued at $23.41 at 07:34 EST, way under its 52-week high of $27.41 and way higher than its 52-week low of $16.61.

Box’s Moving Average

Box’s value is below its 50-day moving average of $25.55 and under its 200-day moving average of $24.51.

Previous days news about Box

  • Stocks making the biggest moves after hours: Salesforce, box, ambarella and more. According to CNBC on Tuesday, 30 November, "Box – Shares of Box rose 8% in after hours trading on Tuesday after beating on the top and bottom lines of its quarterly results. "

More news about Box.

2. Zscaler (ZS) – Premarket: 6.26%

NASDAQ Composite ended the session with Zscaler dropping 0% to $346.97 on Wednesday, after two successive sessions in a row of losses. NASDAQ Composite fell 0% to $15,537.69, following the last session’s downward trend on what was a somewhat positive trend trading session today.

Volume

Today’s last reported volume for Zscaler is 3858780, 113.29% above its average volume of 1809100.

Zscaler’s last close was $346.97, 2.66% below its 52-week high of $356.45.

The company’s growth estimates for the ongoing quarter is a negative 14.3% and positive 20% for the next.

Zscaler’s Revenue

Year-on-year quarterly revenue growth grew by 59.6%, now sitting on 601.91M for the twelve trailing months.

Volatility

Zscaler’s last week, last month’s, and last quarter’s current intraday variation average was 0.47%, 0.42%, and 2.00%, respectively.

Zscaler’s highest amplitude of average volatility was 3.29% (last week), 2.36% (last month), and 2.00% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Zscaler’s stock is considered to be oversold (<=20).

Zscaler’s Stock Yearly Top and Bottom Value

Zscaler’s stock is valued at $346.97 at 07:34 EST, under its 52-week high of $356.45 and way above its 52-week low of $127.00.

Zscaler’s Moving Average

Zscaler’s worth is way above its 50-day moving average of $295.78 and way higher than its 200-day moving average of $241.53.

More news about Zscaler.

3. Li Auto (LI) – Premarket: 5.39%

NASDAQ Composite ended the session with Li Auto dropping 0% to $35.44 on Wednesday, after two consecutive sessions in a row of gains. NASDAQ Composite slid 0% to $15,537.69, following the last session’s downward trend on what was a somewhat positive trend trading session today.

Volume

Today’s last reported volume for Li Auto is 17935100, 157.76% above its average volume of 6958060.

Li Auto’s last close was $35.44, 25.7% below its 52-week high of $47.70.

Li Auto’s Sales

Li Auto’s sales growth is 178.6% for the ongoing quarter and 108.2% for the next. The company’s growth estimates for the present quarter is 75% and a drop 150% for the next.

Li Auto’s Revenue

Year-on-year quarterly revenue growth grew by 158.8%, now sitting on 15.27B for the twelve trailing months.

Volatility

Li Auto’s last week, last month’s, and last quarter’s current intraday variation average was 2.84%, 0.48%, and 2.67%, respectively.

Li Auto’s highest amplitude of average volatility was 3.29% (last week), 2.83% (last month), and 2.67% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Li Auto’s stock is considered to be oversold (<=20).

Li Auto’s Stock Yearly Top and Bottom Value

Li Auto’s stock is valued at $35.44 at 07:34 EST, way under its 52-week high of $47.70 and way higher than its 52-week low of $15.98.

Li Auto’s Moving Average

Li Auto’s worth is way above its 50-day moving average of $29.61 and way above its 200-day moving average of $28.10.

Previous days news about Li Auto

  • Li Auto stock surges toward a 5-month high after big revenue beat, deliveries nearly tripled. According to MarketWatch on Monday, 29 November, "Shares of Li Auto Inc. shot up 7.8% toward a five-month high in premarket trading Monday, after the China-based electric vehicle maker reported third-quarter revenue that rose well above expectations as deliveries nearly tripled, as "strong order intake and users’ rising acceptance of smart electric vehicles" helped offset headwinds from chip supply shortages. "
  • NIO stock forecast: nio inc rises as rival Li Auto triples its quarterly revenue. According to FXStreet on Tuesday, 30 November, "The main news that was pushing the Chinese EV sector higher was the third quarter financial report from Li Auto (NASDAQ: LI). "

More news about Li Auto.

4. Merck (MRK) – Premarket: 5.3%

NYSE Composite ended the session with Merck sliding 0% to $74.91 on Wednesday, following the last session’s upward trend. NYSE Composite slid 0% to $16,318.97, following the last session’s downward trend on what was a somewhat up trend trading session today.

Volume

Today’s last reported volume for Merck is 28194300, 77.28% above its average volume of 15903400.

Merck’s last close was $74.91, 18.04% under its 52-week high of $91.40.

Merck’s Sales

Merck’s sales growth is 0.6% for the current quarter and a decline by 0.8% for the next. The company’s growth estimates for the current quarter and the next is 13.1% and 52%, respectively.

Merck’s Revenue

Year-on-year quarterly revenue growth grew by 4.9%, now sitting on 50.38B for the twelve trailing months.

Volatility

Merck’s last week, last month’s, and last quarter’s current intraday variation average was a negative 4.82%, a negative 0.81%, and a positive 1.53%, respectively.

Merck’s highest amplitude of average volatility was 4.82% (last week), 1.86% (last month), and 1.53% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Merck’s stock is considered to be overbought (>=80).

Merck’s Stock Yearly Top and Bottom Value

Merck’s stock is valued at $74.91 at 07:34 EST, way under its 52-week high of $91.40 and higher than its 52-week low of $68.44.

Merck’s Moving Average

Merck’s worth is below its 50-day moving average of $80.76 and under its 200-day moving average of $76.92.

Previous days news about Merck

  • Omicron: Merck says its Covid-19 anti-viral pill will have similar efficacy against omicron. According to FXStreet on Tuesday, 30 November, "US pharmaceutical giant Merck said on Tuesday that it expected its antiviral pill to show similar activity against any new Covid-19 variant, including Omicron, according to Reuters. "
  • Merck says covid antiviral likely to be active against omicron. According to Bloomberg Quint on Tuesday, 30 November, "However, Merck hasn’t yet done specific research studying the antiviral’s effect against omicron. "
  • Merck heads for worst month since 2009 as covid pill disappoints. According to Bloomberg Quint on Tuesday, 30 November, "On Nov. 4, Merck closed at a record high of $90.54 when the drug, also branded as Lagevrio, received its first authorization from U.K. regulators. "

More news about Merck.

5. POSCO (PKX) – Premarket: 5.13%

NYSE Composite ended the session with POSCO sliding 0% to $55.17 on Wednesday while NYSE Composite dropped 0% to $16,318.97.

Volume

Today’s last reported volume for POSCO is 331478, 66.23% above its average volume of 199406.

POSCO’s last close was $55.17, 40.16% below its 52-week high of $92.19.

POSCO’s Revenue

Year-on-year quarterly revenue growth grew by 33.3%, now sitting on 63.89T for the twelve trailing months.

Volatility

POSCO’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.92%, a negative 0.77%, and a positive 1.61%, respectively.

POSCO’s highest amplitude of average volatility was 2.92% (last week), 1.69% (last month), and 1.61% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

POSCO’s stock is considered to be overbought (>=80).

POSCO’s Stock Yearly Top and Bottom Value

POSCO’s stock is valued at $55.17 at 07:34 EST, way below its 52-week high of $92.19 and higher than its 52-week low of $52.30.

POSCO’s Moving Average

POSCO’s worth is way below its 50-day moving average of $66.73 and way below its 200-day moving average of $74.24.

More news about POSCO.

6. Flex (FLEX) – Premarket: 4.85%

NASDAQ Composite ended the session with Flex falling 0% to $17.10 on Wednesday, after three consecutive sessions in a row of losses. NASDAQ Composite dropped 0% to $15,537.69, following the last session’s downward trend on what was a somewhat up trend exchanging session today.

Volume

Today’s last reported volume for Flex is 4511840, 24.09% above its average volume of 3635780.

Flex’s last close was $17.10, 14.67% under its 52-week high of $20.04.

The company’s growth estimates for the present quarter is 11.1% and a drop 2% for the next.

Flex’s Revenue

Year-on-year quarterly revenue growth grew by 23.1%, now sitting on 25.31B for the twelve trailing months.

Volatility

Flex’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.67%, a negative 0.17%, and a positive 1.90%, respectively.

Flex’s highest amplitude of average volatility was 1.67% (last week), 1.61% (last month), and 1.90% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Flex’s stock is considered to be overbought (>=80).

Flex’s Stock Yearly Top and Bottom Value

Flex’s stock is valued at $17.10 at 07:34 EST, way below its 52-week high of $20.04 and way above its 52-week low of $15.07.

Flex’s Moving Average

Flex’s worth is under its 50-day moving average of $18.31 and below its 200-day moving average of $17.96.

More news about Flex.

7. Canon (CAJ) – Premarket: 4.55%

NYSE Composite ended the session with Canon dropping 0% to $22.00 on Wednesday while NYSE Composite slid 0% to $16,318.97.

Volume

Today’s last reported volume for Canon is 411737, 10.8% above its average volume of 371583.

Canon’s last close was $22.00, 15.19% under its 52-week high of $25.94.

Canon’s Sales

Canon’s sales growth is 18.3% for the present quarter and a decline by 1.4% for the next. The company’s growth estimates for the ongoing quarter and the next is 157.1% and 4.1%, respectively.

Canon’s Revenue

Year-on-year quarterly revenue growth grew by 31%, now sitting on 3.43T for the twelve trailing months.

Volatility

Canon’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.20%, a negative 0.11%, and a positive 1.06%, respectively.

Canon’s highest amplitude of average volatility was 1.35% (last week), 0.80% (last month), and 1.06% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Canon’s stock is considered to be overbought (>=80).

Canon’s Stock Yearly Top and Bottom Value

Canon’s stock is valued at $22.00 at 07:34 EST, way under its 52-week high of $25.94 and way above its 52-week low of $17.65.

Canon’s Moving Average

Canon’s value is below its 50-day moving average of $23.84 and below its 200-day moving average of $23.71.

More news about Canon.

8. Sypris Solutions (SYPR) – Premarket: 4.48%

NASDAQ Composite ended the session with Sypris Solutions falling 0% to $2.68 on Wednesday, after three sequential sessions in a row of losses. NASDAQ Composite fell 0% to $15,537.69, following the last session’s downward trend on what was a somewhat up trend trading session today.

Volume

Today’s last reported volume for Sypris Solutions is 118821, 29.31% below its average volume of 168103.

Sypris Solutions’s last close was $2.68, 66.03% under its 52-week high of $7.89.

Sypris Solutions’s Sales

Sypris Solutions’s sales growth is 5.8% for the current quarter and a decline by 20% for the next.

Sypris Solutions’s Revenue

Year-on-year quarterly revenue growth grew by 15.9%, now sitting on 92.25M for the twelve trailing months.

Volatility

Sypris Solutions’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.43%, a negative 1.88%, and a positive 3.29%, respectively.

Sypris Solutions’s highest amplitude of average volatility was 2.43% (last week), 3.33% (last month), and 3.29% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Sypris Solutions’s stock is considered to be overbought (>=80).

Sypris Solutions’s Stock Yearly Top and Bottom Value

Sypris Solutions’s stock is valued at $2.68 at 07:34 EST, way under its 52-week high of $7.89 and way above its 52-week low of $1.28.

Sypris Solutions’s Moving Average

Sypris Solutions’s worth is way under its 50-day moving average of $3.66 and way below its 200-day moving average of $3.46.

More news about Sypris Solutions.

9. CNH Industrial (CNHI) – Premarket: 4.4%

NYSE Composite ended the session with CNH Industrial dropping 0% to $16.36 on Wednesday, after five consecutive sessions in a row of losses. NYSE Composite fell 0% to $16,318.97, following the last session’s downward trend on what was a somewhat bullish trend trading session today.

Volume

Today’s last reported volume for CNH Industrial is 6567590, 96.49% above its average volume of 3342430.

The company’s growth estimates for the ongoing quarter and the next is 118.2% and 13.3%, respectively.

Volatility

CNH Industrial’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.99%, a negative 0.36%, and a positive 1.54%, respectively.

CNH Industrial’s highest amplitude of average volatility was 2.99% (last week), 1.51% (last month), and 1.54% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

CNH Industrial’s stock is considered to be overbought (>=80).

More news about CNH Industrial.

10. Groupon (GRPN) – Premarket: 4.07%

NASDAQ Composite ended the session with Groupon falling 0% to $20.66 on Wednesday while NASDAQ Composite dropped 0% to $15,537.69.

Volume

Today’s last reported volume for Groupon is 1003500, 1.36% below its average volume of 1017360.

Groupon’s last close was $20.66, 68.06% below its 52-week high of $64.69.

Groupon’s Sales

Groupon’s sales growth is a negative 29.9% for the ongoing quarter and a decline by 29.7% for the next. The company’s growth estimates for the current quarter and the next is a negative 53.3% and a negative 45.1%, respectively.

Groupon’s Revenue

Year-on-year quarterly revenue growth declined by 29.6%, now sitting on 1.09B for the twelve trailing months.

Volatility

Groupon’s last week, last month’s, and last quarter’s current intraday variation average was a negative 4.18%, a negative 0.45%, and a positive 2.73%, respectively.

Groupon’s highest amplitude of average volatility was 4.18% (last week), 3.53% (last month), and 2.73% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Groupon’s stock is considered to be overbought (>=80).

Groupon’s Stock Yearly Top and Bottom Value

Groupon’s stock is valued at $20.66 at 07:34 EST, below its 52-week low of $20.76.

Groupon’s Moving Average

Groupon’s worth is way under its 50-day moving average of $23.36 and way under its 200-day moving average of $33.98.

More news about Groupon.

Most Active Premarket Losers Today

1. Salesforce (CRM) – Premarket: -5.95%

NYSE Composite ended the session with Salesforce falling 0% to $284.96 on Wednesday while NYSE Composite dropped 0% to $16,318.97.

Volume

Today’s last reported volume for Salesforce is 9015700, 81.05% above its average volume of 4979490.

Salesforce’s last close was $284.96, 8.59% below its 52-week high of $311.75.

News about Salesforce today

  • New Salesforce co-ceo bret taylor has growth on the mind. According to today’s article on Bloomberg Quint, "On Tuesday’s earnings call, analysts honed in on MuleSoft, a vendor Salesforce purchased in 2018 that provides tools for customers to connect disparate software programs together, signaling the importance the unit will play in the company’s future. ", "Alongside the Customer 360 strategy, Taylor also led the effort to build Hyperforce, which enables Salesforce programs to run on the major public clouds, an architectural overhaul that could prove critical to the company’s long-term vision."

The company’s growth estimates for the ongoing quarter and the next is a negative 47.1% and a negative 23.1%, respectively.

Salesforce’s Revenue

Year-on-year quarterly revenue growth grew by 22.6%, now sitting on 22.35B for the twelve trailing months.

Volatility

Salesforce’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.49%, a negative 0.31%, and a positive 1.18%, respectively.

Salesforce’s highest amplitude of average volatility was 3.43% (last week), 1.33% (last month), and 1.18% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Salesforce’s stock is considered to be oversold (<=20).

Salesforce’s Stock Yearly Top and Bottom Value

Salesforce’s stock is valued at $284.96 at 07:34 EST, below its 52-week high of $311.75 and way above its 52-week low of $201.51.

Salesforce’s Moving Average

Salesforce’s value is under its 50-day moving average of $287.70 and way higher than its 200-day moving average of $254.07.

Previous days news about Salesforce

  • Salesforce stock down over 6% on weaker-than-expected forecast. According to MarketWatch on Tuesday, 30 November, "For the fiscal fourth quarter, Salesforce projected adjusted earnings of 72 cents to 73 cents a share on sales of $7.22 billion to $7.23 billion. "
  • Salesforce names bret taylor co-ceo. According to The Wall Street Journal on Tuesday, 30 November, "The move restores the co-CEO structure that Salesforce had until last year when Keith Block stepped down."

More news about Salesforce.

2. Telefonica (TEF) – Premarket: -3.77%

NYSE Composite ended the session with Telefonica falling 0% to $4.51 on Wednesday, after three sequential sessions in a row of gains. NYSE Composite fell 0% to $16,318.97, following the last session’s downward trend on what was a somewhat up trend trading session today.

Volume

Today’s last reported volume for Telefonica is 2868300, 47.11% above its average volume of 1949630.

Telefonica’s last close was $4.51, 12.77% below its 52-week high of $5.17.

Telefonica’s Revenue

Year-on-year quarterly revenue growth declined by 3.9%, now sitting on 42.54B for the twelve trailing months.

Volatility

Telefonica’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.91%, a negative 0.02%, and a positive 1.35%, respectively.

Telefonica’s highest amplitude of average volatility was 1.36% (last week), 1.72% (last month), and 1.35% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Telefonica’s stock is considered to be oversold (<=20).

Telefonica’s Stock Yearly Top and Bottom Value

Telefonica’s stock is valued at $4.51 at 07:34 EST, way under its 52-week high of $5.17 and way higher than its 52-week low of $3.89.

Telefonica’s Moving Average

Telefonica’s worth is under its 50-day moving average of $4.55 and under its 200-day moving average of $4.74.

More news about Telefonica.

3. Moderna (MRNA) – Premarket: -2.68%

NASDAQ Composite ended the session with Moderna falling 0% to $352.43 on Wednesday while NASDAQ Composite slid 0% to $15,537.69.

Volume

Today’s last reported volume for Moderna is 24111200, 81.37% above its average volume of 13293500.

Moderna’s last close was $352.43, 29.16% below its 52-week high of $497.49.

Moderna’s Sales

Moderna’s sales growth is 8216.6% for the present quarter and 1202.8% for the next. The company’s growth estimates for the ongoing quarter and the next is 1694.9% and 1681.2%, respectively.

Moderna’s Revenue

Year-on-year quarterly revenue growth grew by 6398.5%, now sitting on 7.02B for the twelve trailing months.

Volatility

Moderna’s last week, last month’s, and last quarter’s current intraday variation average was 9.27%, 0.18%, and 4.26%, respectively.

Moderna’s highest amplitude of average volatility was 12.31% (last week), 6.06% (last month), and 4.26% (last quarter), respectively.

Moderna’s Stock Yearly Top and Bottom Value

Moderna’s stock is valued at $352.43 at 07:34 EST, way below its 52-week high of $497.49 and way above its 52-week low of $83.83.

Moderna’s Moving Average

Moderna’s worth is higher than its 50-day moving average of $334.78 and way above its 200-day moving average of $297.28.

Previous days news about Moderna

  • Moderna says it might release a modified Covid-19 vaccine for the omicron variant by early 2022. According to Business Insider on Monday, 29 November, "Since early 2021, Moderna has advanced a comprehensive strategy to anticipate new variants of concern," the company said. "
  • Moderna (mrna) stock price and forecast: is Moderna going to top $400 as Pfizer and BNTX all surge?. According to FXStreet on Monday, 29 November, "$360 is the last resistance and Moderna (MRNA) is trading here in Monday’s premarket so it will be interesting to see if it can hold these gains. "
  • Moderna CEO weighs in on omicron variant: we believe it's 'already present in most countries'. According to Benzinga on Monday, 29 November, "MRNA Price Action: Moderna has traded as high as $497.49 and as low as $98.65 over a 52-week period."
  • Moderna extends 2-day gain to 32% after it says omicron vaccine will be ready in early 2022. According to Business Insider on Monday, 29 November, "The emergence of a new COVID-19 variant sparked a big rally in shares of Moderna on Monday as the company announced plans to combat the virus with more vaccines.", "But Moderna thinks it could develop a new vaccine to combat Omicron relatively quickly if it’s needed, thanks to its mRNA platform that enables quick adaption to new virus variants. "

More news about Moderna.

4. Arcturus Therapeutics (ARCT) – Premarket: -2.39%

NASDAQ Composite ended the session with Arcturus Therapeutics sliding 0% to $39.75 on Wednesday while NASDAQ Composite slid 0% to $15,537.69.

Volume

Today’s last reported volume for Arcturus Therapeutics is 655354, 34.29% above its average volume of 488008.

Arcturus Therapeutics’s last close was $39.75, 69.35% below its 52-week high of $129.71.

Arcturus Therapeutics’s Sales

Arcturus Therapeutics’s sales growth is 625.3% for the present quarter and 1814.2% for the next. The company’s growth estimates for the current quarter is a negative 72.8% and positive 6.4% for the next.

Arcturus Therapeutics’s Revenue

Year-on-year quarterly revenue growth declined by 13.8%, now sitting on 8.7M for the twelve trailing months.

Volatility

Arcturus Therapeutics’s last week, last month’s, and last quarter’s current intraday variation average was a positive 3.47%, a negative 0.92%, and a positive 3.72%, respectively.

Arcturus Therapeutics’s highest amplitude of average volatility was 7.25% (last week), 4.63% (last month), and 3.72% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Arcturus Therapeutics’s stock is considered to be oversold (<=20).

Arcturus Therapeutics’s Stock Yearly Top and Bottom Value

Arcturus Therapeutics’s stock is valued at $39.75 at 07:34 EST, way under its 52-week high of $129.71 and way above its 52-week low of $24.87.

Arcturus Therapeutics’s Moving Average

Arcturus Therapeutics’s value is way under its 50-day moving average of $44.81 and under its 200-day moving average of $40.32.

More news about Arcturus Therapeutics.

5. BioNTech SE (BNTX) – Premarket: -2.04%

NASDAQ Composite ended the session with BioNTech SE dropping 0% to $351.74 on Wednesday while NASDAQ Composite dropped 0% to $15,537.69.

Volume

Today’s last reported volume for BioNTech SE is 4719960, 42.45% above its average volume of 3313260.

BioNTech SE’s last close was $351.74, 24.19% below its 52-week high of $464.00.

The company’s growth estimates for the current quarter and the next is 1188.8% and 438%, respectively.

BioNTech SE’s Revenue

Year-on-year quarterly revenue growth grew by 12630.2%, now sitting on 7.77B for the twelve trailing months.

Volatility

BioNTech SE’s last week, last month’s, and last quarter’s current intraday variation average was 5.10%, 1.21%, and 4.57%, respectively.

BioNTech SE’s highest amplitude of average volatility was 7.14% (last week), 6.21% (last month), and 4.57% (last quarter), respectively.

BioNTech SE’s Stock Yearly Top and Bottom Value

BioNTech SE’s stock is valued at $351.74 at 07:34 EST, way under its 52-week high of $464.00 and way higher than its 52-week low of $80.55.

BioNTech SE’s Moving Average

BioNTech SE’s value is way higher than its 50-day moving average of $269.93 and way above its 200-day moving average of $268.56.

More news about BioNTech SE.

6. Zebra Technologies (ZBRA) – Premarket: -1.83%

NASDAQ Composite ended the session with Zebra Technologies falling 0% to $588.78 on Wednesday, following the last session’s downward trend. NASDAQ Composite fell 0% to $15,537.69, following the last session’s downward trend on what was a somewhat positive trend exchanging session today.

Volume

Today’s last reported volume for Zebra Technologies is 457972, 90.8% above its average volume of 240022.

Zebra Technologies’s last close was $588.78, 4.12% below its 52-week high of $614.10.

Zebra Technologies’s Sales

Zebra Technologies’s sales growth is 23.6% for the present quarter and 7.8% for the next. The company’s growth estimates for the ongoing quarter is 24.2% and a drop 6.1% for the next.

Zebra Technologies’s Revenue

Year-on-year quarterly revenue growth grew by 44%, now sitting on 5.16B for the twelve trailing months.

Volatility

Zebra Technologies’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.53%, a positive 0.43%, and a positive 1.55%, respectively.

Zebra Technologies’s highest amplitude of average volatility was 2.39% (last week), 1.69% (last month), and 1.55% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Zebra Technologies’s stock is considered to be overbought (>=80).

Zebra Technologies’s Stock Yearly Top and Bottom Value

Zebra Technologies’s stock is valued at $588.78 at 07:34 EST, under its 52-week high of $614.10 and way above its 52-week low of $333.06.

Zebra Technologies’s Moving Average

Zebra Technologies’s worth is higher than its 50-day moving average of $535.96 and way above its 200-day moving average of $532.77.

More news about Zebra Technologies.

7. ImmunoGen (IMGN) – Premarket: -1.6%

NASDAQ Composite ended the session with ImmunoGen falling 0% to $6.17 on Wednesday while NASDAQ Composite dropped 0% to $15,537.69.

Volume

Today’s last reported volume for ImmunoGen is 58427200, 3678.06% above its average volume of 1546490.

ImmunoGen’s last close was $6.17, 43.29% under its 52-week high of $10.88.

ImmunoGen’s Sales

ImmunoGen’s sales growth is 23.9% for the present quarter and a decline by 78% for the next. The company’s growth estimates for the present quarter and the next is a negative 38.5% and a negative 237.5%, respectively.

ImmunoGen’s Revenue

Year-on-year quarterly revenue growth grew by 18.2%, now sitting on 134.72M for the twelve trailing months.

Volatility

ImmunoGen’s last week, last month’s, and last quarter’s current intraday variation average was 8.78%, 0.04%, and 2.48%, respectively.

ImmunoGen’s highest amplitude of average volatility was 11.15% (last week), 4.27% (last month), and 2.48% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

ImmunoGen’s stock is considered to be oversold (<=20).

ImmunoGen’s Stock Yearly Top and Bottom Value

ImmunoGen’s stock is valued at $6.17 at 07:34 EST, way below its 52-week high of $10.88 and way above its 52-week low of $4.97.

ImmunoGen’s Moving Average

ImmunoGen’s worth is higher than its 50-day moving average of $5.99 and higher than its 200-day moving average of $6.15.

More news about ImmunoGen.

8. CME Group (CME) – Premarket: -1.52%

NASDAQ Composite ended the session with CME Group dropping 0% to $220.52 on Wednesday, following the last session’s downward trend. NASDAQ Composite fell 0% to $15,537.69, following the last session’s downward trend on what was a somewhat up trend trading session today.

Volume

Today’s last reported volume for CME Group is 2659970, 104% above its average volume of 1303900.

CME Group’s last close was $220.52, 4.49% under its 52-week high of $230.89.

The company’s growth estimates for the ongoing quarter and the next is 17.4% and 18.7%, respectively.

CME Group’s Revenue

Year-on-year quarterly revenue growth declined by 0.2%, now sitting on 4.6B for the twelve trailing months.

Volatility

CME Group’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.27%, a positive 0.05%, and a positive 0.90%, respectively.

CME Group’s highest amplitude of average volatility was 2.22% (last week), 0.84% (last month), and 0.90% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

CME Group’s stock is considered to be overbought (>=80).

CME Group’s Stock Yearly Top and Bottom Value

CME Group’s stock is valued at $220.52 at 07:34 EST, under its 52-week high of $230.89 and way higher than its 52-week low of $159.46.

CME Group’s Moving Average

CME Group’s worth is above its 50-day moving average of $208.96 and above its 200-day moving average of $208.09.

More news about CME Group.

9. Novavax (NVAX) – Premarket: -1.51%

NASDAQ Composite ended the session with Novavax sliding 0% to $208.63 on Wednesday, following the last session’s upward trend. NASDAQ Composite fell 0% to $15,537.69, following the last session’s downward trend on what was a somewhat bullish trend exchanging session today.

Volume

Today’s last reported volume for Novavax is 6036890, 18.22% above its average volume of 5106240.

Novavax’s last close was $208.63, 37.1% below its 52-week high of $331.68.

The company’s growth estimates for the present quarter is a negative 21.8% and positive 213.7% for the next.

Novavax’s Revenue

Year-on-year quarterly revenue growth grew by 13.9%, now sitting on 1.2B for the twelve trailing months.

Volatility

Novavax’s last week, last month’s, and last quarter’s current intraday variation average was 1.38%, 0.98%, and 4.85%, respectively.

Novavax’s highest amplitude of average volatility was 9.63% (last week), 5.42% (last month), and 4.85% (last quarter), respectively.

Novavax’s Stock Yearly Top and Bottom Value

Novavax’s stock is valued at $208.63 at 07:34 EST, way below its 52-week high of $331.68 and way higher than its 52-week low of $84.60.

Novavax’s Moving Average

Novavax’s value is way above its 50-day moving average of $174.69 and higher than its 200-day moving average of $194.46.

Previous days news about Novavax

  • NVAX investor alert: hagens berman, national trial attorneys, notifies Novavax (nvax) investors of lead plaintiff opportunity in securities fraud class action. According to Benzinga on Monday, 29 November, "Then, on Oct. 19, 2021 Politico reported, citing anonymous sources, that Novavax "faces significant hurdles in proving it can manufacture a shot that meets regulators’ quality standards," the company’s "issues are more concerning than previously understood, according to two of the people with direct knowledge of the matter," and the company could take until the end of 2022 to resolve its manufacturing issues.", "Whistleblowers: Persons with non-public information regarding Novavax should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. "

More news about Novavax.

10. Huazhu Group (HTHT) – Premarket: -1.42%

NASDAQ Composite ended the session with Huazhu Group falling 0% to $39.52 on Wednesday while NASDAQ Composite dropped 0% to $15,537.69.

Volume

Today’s last reported volume for Huazhu Group is 2469980, 104.85% above its average volume of 1205710.

Huazhu Group’s last close was $39.52, 38.76% below its 52-week high of $64.53.

Huazhu Group’s Sales

Huazhu Group’s sales growth is 7.2% for the present quarter and 26.9% for the next.

Huazhu Group’s Revenue

Year-on-year quarterly revenue growth grew by 15.6%, now sitting on 10.51B for the twelve trailing months.

Volatility

Huazhu Group’s last week, last month’s, and last quarter’s current intraday variation average was a negative 4.08%, a negative 0.94%, and a positive 2.04%, respectively.

Huazhu Group’s highest amplitude of average volatility was 4.72% (last week), 2.62% (last month), and 2.04% (last quarter), respectively.

Huazhu Group’s Stock Yearly Top and Bottom Value

Huazhu Group’s stock is valued at $39.52 at 07:34 EST, way under its 52-week high of $64.53 and higher than its 52-week low of $39.01.

Huazhu Group’s Moving Average

Huazhu Group’s worth is way below its 50-day moving average of $47.56 and way under its 200-day moving average of $50.44.

More news about Huazhu Group.

Stay up to date with our premarket winners and losers daily report

LEAVE A REPLY

Please enter your comment!
Please enter your name here